Physician

David Clayton Smith, M.D.

According to 2025 Medicare claims, David Smith, M.D. (NPI: 1154575637) practices internal medicine in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is GADZOOM HEALTH LLC (NPI: 1770187163; TIN: 854037021) and primary practice location at 84043-6651. Smith is affiliated with the Care Partners ACO, LLC (ACO ID: A5350), Sound Physicians Long Term Care Managment II (ACO ID: A5538), and CareConnectMD DCE LLC (ACO ID: D0131), participating under both the MSSP and REACH models.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 629 traditional Medicare patients, billed 6,019 HCPCS/CPT codes, and received $589,779 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 13,822 prescription claims across 475 beneficiaries totaling $1,099,840 in drug costs, led by Eliquis (Apixaban). DME data shows 49 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $39,683 to $589,779. Similarly, Part D prescription costs have risen steadily, from $1,279 to $1,099,840. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,613 and ending at $1,960.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	467	675	$39,683
2016	391	812	$52,282
2017	470	904	$53,225
2018	258	638	$49,010
2019	161	299	$26,597
2020	299	406	$52,934
2021	418	966	$92,452
2022	410	958	$85,975
2023	626	3,734	$359,151
2024	629	6,019	$589,779

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	48	$1,279
2016	86	210	$12,289
2017	120	269	$12,056
2018	122	302	$13,663
2019	51	157	$7,884
2020	15	56	$2,125
2021	181	845	$39,555
2022	249	1,925	$186,304
2023	424	5,475	$364,389
2024	475	13,822	$1,099,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	21	$15,923
2018	N/R	45	$1,259
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	11	73	$4,078
2022	25	100	$5,579
2023	N/R	115	$6,237
2024	N/R	49	$1,393

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	270	316	$134
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	547	3,518	$113
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	304	1,299	$79
99497	Advance care planning, first 30 minutes	446	712	$56
G3002	Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha	36	50	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	727	11,151	$231,284
Xeljanz Xr	Tofacitinib Citrate	12	360	$75,368
Nuedexta	Dextromethorphan Hbr/Quinidine	94	1,309	$72,592
Trulicity	Dulaglutide	52	1,456	$54,052
Jardiance	Empagliflozin	161	2,488	$53,741

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$835
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	36	$557

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David Clayton Smith, M.D.?

Tedicare shows public-source Medicare data for David Clayton Smith, M.D. (NPI 1154575637), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Clayton Smith, M.D. have ACO affiliation data?

David Clayton Smith, M.D. is shown with ACO affiliation data for Care Partners ACO, LLC (MSSP, ACO ID A5350), Sound Physicians Long Term Care Managment II (MSSP, ACO ID A5538), and CareConnectMD DCE LLC (REACH, ACO ID D0131).

What billing organization is linked to David Clayton Smith, M.D.?

David Clayton Smith, M.D. is linked to GADZOOM HEALTH LLC (billing NPI 1770187163) in the available physician profile data.

Does David Clayton Smith, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.